newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference

CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that Douglas E.